Reports for NATCO PHARMA (CANADA) INC

Company Name

NATCO PHARMA (CANADA) INC

Totals

Shortage reports

29

Actual shortage: 11 (38%)
Anticipated shortage: 1 (3%)
Avoided shortage: 0 (0%)
Resolved: 17 (59%)

Discontinuation Reports

0

To be discontinued: 0
Discontinued: 0
Reversed: 0

Late reports

1 (3%)

Overdue reports

5 (42%)

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
NAT-DONEPEZIL 5MG TABLET Resolved 2024-02-02 2024-02-21 218262
NAT-EVEROLIMUS 2.5MG TABLET Actual shortage 2024-04-29 2024-06-12 226575
NAT-MONTELUKAST 4MG TABLET (CHEWABLE) Actual shortage 2024-04-29 2024-04-30 226579
NAT-MONTELUKAST 5MG TABLET (CHEWABLE) Actual shortage 2024-04-29 2024-04-30 226582
NAT-DONEPEZIL 5MG TABLET Actual shortage 2024-04-29 2024-04-30 226585
NAT-QUETIAPINE 150MG TABLET Actual shortage 2024-04-29 2024-04-30 226594
NAT-DONEPEZIL 5MG TABLET Actual shortage 2024-06-13 2024-06-14 230392
NAT-OMEPRAZOLE DR 20MG TABLET (DELAYED-RELEASE) Actual shortage 2024-06-13 2024-06-14 230400
NAT-ONDANSETRON 4MG TABLET Anticipated shortage 2024-06-13 2024-06-13 230407

Showing 21 to 29 of 29

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports

Showing 1 to 0 of 0